Delivering Prudent Healthcare in Wales »Prudent healthcare principles ensure patients receive the most appropriate treatments to achieve mutually-agreed goals.Learn more »
Heart disease falling in Wales, new report reveals
The number of people living with coronary heart disease in Wales is falling but it still claims the lives of more than 4,300 people a year, a new report published today shows.
- Welsh Government’s Nest scheme helps another 5,000 people in fuel poverty with their energy bills
- Welsh Government support will accelerate job creation in Wrexham
Featured Article »Landmark Social Services law receives Royal Assent
- Heart disease falling in Wales, new report reveals
In this section
- Business and economy
- Children and young people
- Culture and sport
- Education and skills
- Environment and countryside
- Equality and diversity
- Health and social care
- Amending the Environmental Damage (Prevention and Remediation) Regulations 2009 to transpose Article 38 of the Offshore Safety Directive
- Extending access to intermediary services for descendants and relatives of adopted people
- Renting Homes – Illustrative Model Contract
- Statutory Guidance to the Independent Remuneration Panel for Wales in relation to the salaries of Local Authority Chief Executives
- The Ireland Wales Cooperation Programme 2014-2020
- Active Travel Action Plan
Featured consultation »Draft Technical Advice Note 1: Joint Housing Land Availability Studies
72 days left
Section highlightThe Gender-based Violence, Domestic Abuse and Sexual Violence (Wales) Bill
The Bill aims to improve the Public Sector response in Wales to gender-based violence, domestic abuse and sexual violence.
Legislative programme 2013 - 2014 »
The First Minister detailed the 8 bills in the Welsh Government’s 5-year Legislative Programme that will be brought forward during the 3rd year of the Welsh Assembly.Learn more »
Section highlightProject pipeline update - June 2014
Our pipeline provides visibility of infrastructure investment activity across Wales.
1st Supplementary Budget 2014-15 »
The 1st Supplementary Budget proposes a number of changes to the Final Budget for 2014-15, which was published in December 2013.Learn more »
- Statistics & Research
Upcoming calendar »
See the schedule for all statistics and research releases.View upcoming calendar »
African Horse Sickness
Background to the disease
African Horse Sickness (AHS) is a disease that is spread by midges. Dogs have been known to be infected by eating infected horsemeat. It has never occurred in the UK, but is found in Southern Africa. An outbreak occurred in Spain relatively recently, which was associated with the import of infected zebras from Africa.
The spread of disease is influenced by climatic conditions including warm, moist weather and high rainfall, which favour the spread of carrier insects (such as midges) as well as spread by wind dispersal.
The clinical signs seen are dependent upon what form of the disease is present:
- in the most acute form, which has a short incubation period of only three to five days, affected horses have a high fever, severely laboured breathing, coughing and profuse discharge from the nostrils. The mortality rate is very high with up to 95% of horses dying within a week
- in the cardiac form of the disease, which has an incubation period of from seven to fourteen days, swellings are present over the head and eyelids, lips, cheeks and under the jaw. The mortality rate is around 60 per cent and death results from heart failure
- the mixed form of the disease is a combination of the above two types. It has an incubation period of from five to seven days and the disease shows itself initially by mild respiratory signs followed by the typical swellings of the cardiac form
- horse sickness fever is the mildest form, characterised by a fever with low temperatures in the morning rising to a high peak in the afternoon.
If you suspect signs of any of African Horse Sickness you must immediately notify your local Animal Health Veterinary Laboratories Agency Office (external link).
No vaccine for AHS is currently licensed in the European Union (EU). Use of a modified live vaccine for AHS (such as the one being produced by Onderstepoort Biological Products Ltd in South Africa) carries a risk of vaccine virus reversion to wild type. This means that the virus used in the vaccine could potentially undergo changes whereby it could actually infect the carrier insects and, subsequently, susceptible horses. Currently the vaccine will not be considered for use in the UK other than in an emergency situation.
African Horse Sickness (Wales) Regulations 2013
The African Horse Sickness (Wales) Regulations 2013 (external link) will only be used during an outbreak or suspected outbreak of African Horse Sickness (AHS). The risk of an AHS outbreak in GB is considered to be low. However, recent outbreaks of Bluetongue and Schmallenberg have demonstrated the risk posed by animal diseases spread by Cullicoides midges. Similar regulations are already in force in England and Scotland.